Over 5 million Americans are affected by fibromyalgia - a complex and often misunderstood chronic pain condition. Symptoms of fibromyalgia can vary depending on the person, weather, or even time of day. Some of the more common symptoms include:
The exact cause of fibromyalgia is unknown, but studies show that sufferers have a heightened sensitivity to pain. And although there is no cure for fibromyalgia, doctors and researchers are studying new ways to potentially reduce symptoms and improve quality of life.
Right now, doctors at 30 locations across the US are conducting a new phase 3 clinical trial for fibromyalgia, called the RESILIENT Study. The study is for an investigational drug that may help improve fibromyalgia symptoms and sleep quality when taken nightly at bedtime for 14 weeks.
Participants in the RESILIENT Study will receive all study-related care at no cost. You will also be compensated for your time and travel to attend periodic visits at your local study doctor’s office to monitor your progress (up to 6 visits over a 4 month period).
Clinical studies or trials are used to learn about the safety and effectiveness of new medications, medical devices, medical procedures, or other types of intervention. Although there are many types of clinical trials, all must conform to strict rules set by the U.S. Food and Drug Administration (FDA). These rules help protect the rights and safety of those who volunteer to take part in clinical trials.
As with all clinical studies, your participation is completely voluntary. You may leave the study at any time without any effect on your future medical care.
See If You Qualify
If you suffer from fibromyalgia and are 18 - 65 years old, you may be eligible to participate in the RESILIENT Study. To see if you might qualify, and to connect with a local study center to learn more, please take the questionnaire below.